Skip to content

The effect of using Burn assessment wean program in adult open heart surgery patients

The effect of using Burn assessment wean program on the duration of mechanical ventilation and hemodynamic and respiratory criteria in adult open heart surgery patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20201207049629N1
Enrollment
78
Registered
2020-12-29
Start date
2020-12-21
Completion date
Unknown
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: pulmonary heart diseases. Condition 2: Open heart surgery patients. Other pulmonary heart diseases

Interventions

Intervention 1: Intervention group: training sessions before the intervention. Evaluates the patient's respiratory function. The range of three-choice questions is "Yes, No, Not Evaluated", where yes

Sponsors

Shahid Rajaei Cardiovascular Training, Research and Treatment Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: All patients are candidates for cardiopulmonary bypass surgery

Exclusion criteria

Exclusion criteria: Be under 18 years old and over 60 years old Have a history of heart surgery Emergency cardiac surgery

Design outcomes

Primary

MeasureTime frame
Burn check list assessment weaning program. Timepoint: When performing the intervention. Method of measurement: It has 26 terms, 12 of which are general assessment tools and 14 of which assess the patient 's respiratory function. The range of three-choice questions is yes, no, not evaluated, yes, they get a score of one and no, and not evaluated, they get a score of zero. The total readiness assessment scores are 26.The weaning process can begin when the patient is 17 or older.;Hemodynamic criteria(Blood pressure, heart rate, central venous pressure). Timepoint: Measurement of hemodynamic and criteria before the intervention (initial 2 hours of patient admission to the intensive care unit) and during the intervention process (separation from mechanical ventilation) and after the intervention (2 hours after separation from mechanical ventilation). Method of measurement: Arterial Blood pressure monitor;Cardiovascular monitoring device? Central venous pressure monitoring.;Respiratory criteria(arterial blood gases). Timepoint: Before the weaning process, one arterial blood gas will be taken and during the separation process, 2 arterial blood gases will be taken every 2 hours and after the separation process, 2 arterial blood gases will be taken every 2 hours. Method of measurement: Laboratory tests.

Secondary

MeasureTime frame
Length of mechanical ventilation. Timepoint: Upon completion of the intervention and successful weaning from the mechanical ventilation. Method of measurement: The length of time the patient is under mechanical ventilation.;Amount of laboratory tests and biochemical markers (sodium, magnesium, calcium, phosphorus, troponin, potassium, hemoglobin, creatinine phosphokinase). Timepoint: Tests (sodium, magnesium, calcium, phosphorus, potassium, hemoglobin, troponin, creatinine phosphokinase) will be checked before the intervention and when entering the special ward. Method of measurement: laboratory test.;Number of re-intubations. Timepoint: After the intervention and re-intubation if necessary. Method of measurement: Frequency of re-intubation.;Drainage volume and urinary efficiency. Timepoint: Before the intervention and when entering the intensive care unit, during the separation process, after the intervention. Method of measurement: Drainage The amount of fluid drained from the chest tube The administrative efficiency of the amount of urine drained.;Duration of surgery. Timepoint: After the surgical procedure. Method of measurement: Duration from start to end of heart surgery.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFateme Falamarzi

Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences

fatemafalamarzi@gmail.com+98 71 3229 6349

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026